Capricor Therapeutics (CAPR) Leases (2021 - 2025)
Capricor Therapeutics (CAPR) has 6 years of Leases data on record, last reported at $13.9 million in Q3 2025.
- For Q3 2025, Leases rose 828.65% year-over-year to $13.9 million; the TTM value through Sep 2025 reached $13.9 million, up 828.65%, while the annual FY2024 figure was $1.3 million, 35.98% down from the prior year.
- Leases reached $13.9 million in Q3 2025 per CAPR's latest filing, up from $939204.0 in the prior quarter.
- Across five years, Leases topped out at $13.9 million in Q3 2025 and bottomed at $939204.0 in Q2 2025.
- Average Leases over 5 years is $2.7 million, with a median of $2.1 million recorded in 2023.
- The widest YoY moves for Leases: up 828.65% in 2025, down 44.75% in 2025.
- A 5-year view of Leases shows it stood at $2.8 million in 2021, then dropped by 16.72% to $2.3 million in 2022, then dropped by 12.76% to $2.1 million in 2023, then crashed by 35.98% to $1.3 million in 2024, then surged by 961.29% to $13.9 million in 2025.
- Per Business Quant database, its latest 3 readings for Leases were $13.9 million in Q3 2025, $939204.0 in Q2 2025, and $1.1 million in Q1 2025.